Background Accurate molecular diagnostic tests are necessary for confirming a diagnosis of
coronavirus disease 2019 (COVID-19). Direct detection of severe acute respiratory …

As the world navigates the coronavirus disease 2019 (COVID-19) pandemic, there is a
growing need to assess its impact in patients with autoimmune rheumatic diseases, such as …

Objective To evaluate seroreactivity and disease flares after COVID‐19 vaccination in a
multiethnic/multiracial cohort of patients with systemic lupus erythematosus (SLE). Methods …

Abstract Background Disease-modifying therapies (DMTs) for multiple sclerosis (MS) target
immunity and have the potential to increase the risk of severe acute respiratory syndrome …

Aim To determine characteristics associated with more severe outcomes in a global registry
of people with systemic lupus erythematosus (SLE) and COVID-19. Methods People with …

Objectives Our aim was to evaluate systemic lupus erythematosus (SLE) disease activity
and SARS-CoV-2-specific immune responses after BNT162b2 vaccination. Methods In this …

Objectives The impact of rheumatic diseases on COVID-19 infection remains poorly
investigated. Here we performed a systematic review and meta-analysis to evaluate the …

Objectives To evaluate risk factors associated with unfavourable outcomes: emergency care,
hospitalisation, admission to intensive care unit (ICU), mechanical ventilation and death in …

Patients with rheumatic diseases are often more susceptible to different bacteria and viruses
because of immune impairment, but it is not clear whether there is a higher risk of infection …

Objective Racial/ethnic minorities experience more severe outcomes of coronavirus disease
2019 (COVID‐19) in the general US population. This study was undertaken to examine the …